ArticleMolecules (Basel, Switzerland)2022

The Ameliorative Effect of Empagliflozin in Vigabatrin-Induced Cerebellar/Neurobehavioral Deficits: Targeting mTOR/AMPK/SIRT-1 Signaling Pathways.

Rabab M Amer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.